ArticleCancer immunology, immunotherapy : CII2023

CiTSA: a comprehensive platform provides experimentally supported signatures of cancer immunotherapy and analysis tools based on bulk and scRNA-seq data.

Feng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.